Keryx says anemia drug succeeds in study of kidney patients

March 29 (Reuters) - Keryx Biopharmaceuticals Inc

on Tuesday said its drug to treat iron deficiency anemia in

chronic kidney disease patients not yet requiring dialysis met

the goals of a late stage...

Read more